T Cells and Regulated Cell Death: Kill or Be Killed
- PMID: 30635093
- PMCID: PMC7325157
- DOI: 10.1016/bs.ircmb.2018.07.004
T Cells and Regulated Cell Death: Kill or Be Killed
Abstract
Cell death plays two major complementary roles in T cell biology: mediating the removal of cells that are targeted by T cells and the removal of T cells themselves. T cells serve as major actors in the adaptive immune response and function by selectively killing cells which are infected or dysfunctional. This feature is highly involved during homeostatic maintenance, and is relied upon and modulated in the context of cancer immunotherapy. The vital recognition and elimination of both autoreactive T cells and cells which are unable to recognize threats is a highly selective and regulated process. Moreover, detection of potential threats will result in the activation and expansion of T cells, which on resolution of the immune response will need to be eliminated. The culling of these T cells can be executed via a multitude of cell death pathways which are used in context-specific manners. Failure of these processes may result in an accumulation of misdirected or dysfunctional T cells, leading to complications such as autoimmunity or cancer. This review will focus on the role of cell death regulation in the maintenance of T cell homeostasis, as well as T cell-mediated elimination of infected or dysfunctional cells, and will summarize and discuss the current knowledge of the cellular mechanisms which are implicated in these processes.
Keywords: Apoptosis; Cancer immunotherapy; Cell death; Ferroptosis; Granzymes; Immunosurveillance; Necroptosis; Pyroptosis; T cell.
Copyright © 2019 Elsevier Inc. All rights reserved.
Figures


Similar articles
-
Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.Immunol Rev. 2017 Nov;280(1):126-148. doi: 10.1111/imr.12574. Immunol Rev. 2017. PMID: 29027218 Review.
-
Inflammatory cell death induced by cytotoxic lymphocytes: a dangerous but necessary liaison.FEBS J. 2022 Aug;289(15):4398-4415. doi: 10.1111/febs.16093. Epub 2021 Jul 17. FEBS J. 2022. PMID: 34174027 Review.
-
How Do Cytotoxic Lymphocytes Kill Cancer Cells?Clin Cancer Res. 2015 Nov 15;21(22):5047-56. doi: 10.1158/1078-0432.CCR-15-0685. Clin Cancer Res. 2015. PMID: 26567364 Review.
-
Redox biology of regulated cell death in cancer: A focus on necroptosis and ferroptosis.Free Radic Biol Med. 2019 Apr;134:177-189. doi: 10.1016/j.freeradbiomed.2019.01.008. Epub 2019 Jan 10. Free Radic Biol Med. 2019. PMID: 30639617 Review.
-
From cancer immunosurveillance to cancer immunotherapy.Immunol Rev. 2007 Dec;220:82-101. doi: 10.1111/j.1600-065X.2007.00566.x. Immunol Rev. 2007. PMID: 17979841 Review.
Cited by
-
Transcriptional effects of 177Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude mice.EJNMMI Res. 2019 Mar 20;9(1):28. doi: 10.1186/s13550-019-0500-2. EJNMMI Res. 2019. PMID: 30895393 Free PMC article.
-
Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints.Front Immunol. 2025 Jan 8;15:1482291. doi: 10.3389/fimmu.2024.1482291. eCollection 2024. Front Immunol. 2025. PMID: 39845973 Free PMC article. Review.
-
IRF2 loss is associated with reduced MHC I pathway transcripts in subsets of most human cancers and causes resistance to checkpoint immunotherapy in human and mouse melanomas.J Exp Clin Cancer Res. 2024 Oct 2;43(1):276. doi: 10.1186/s13046-024-03187-5. J Exp Clin Cancer Res. 2024. PMID: 39354629 Free PMC article.
-
Trial watch: intratumoral immunotherapy.Oncoimmunology. 2021 Oct 15;10(1):1984677. doi: 10.1080/2162402X.2021.1984677. eCollection 2021. Oncoimmunology. 2021. PMID: 34676147 Free PMC article. Review.
-
Ferroptosis: A New Promising Target for Lung Cancer Therapy.Oxid Med Cell Longev. 2021 Sep 25;2021:8457521. doi: 10.1155/2021/8457521. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34616505 Free PMC article. Review.
References
-
- Abdool K, Cretney E, Brooks AD, Kelly JM, Swann J, Shanker A, Bere EW Jr., Yokoyama WM, Ortaldo JR, Smyth MJ, Sayers TJ, 2006. NK cells use NKG2D to recognize a mouse renal cancer (Renca), yet require intercellular adhesion molecule-1 expression on the tumor cells for optimal perforin-dependent effector function. J Immunol 177, 2575–2583. https://doi.org/177/4/2575 [pii] - PubMed
-
- Afshar-Sterle S, Zotos D, Bernard NJ, Scherger AK, Rödling L, Alsop AE, Walker J, Masson F, Belz GT, Corcoran LM, O’reilly LA, Strasser A, Smyth MJ, Johnstone R, Tarlinton DM, Nutt SL, Kallies A, 2014. Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas. Nat. Med 20, 283–290. 10.1038/nm.3442 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources